End-plate acetylcholine receptor: Structure, mechanism, pharmacology, and disease

Physiological Reviews

Volumn 92, Issue 3, 2012, Pages 1189-1234

  Sine, Steven M ^a  

^a MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR; COBROTOXIN; CYSTEINE LOOP LIGAND GATED ION CHANNEL RECEPTOR; POSTSYNAPTIC RECEPTOR;

ARTICLE; CELL COMMUNICATION; CENTRAL NERVOUS SYSTEM; HUMAN; NERVE ENDING; NEUROMUSCULAR ELECTRICAL STIMULATION; NONHUMAN; PATCH CLAMP; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN STRUCTURE; SYNAPTIC TRANSMISSION; VAGUS NERVE STIMULATION;

ACETYLCHOLINE; ACTION POTENTIALS; ANIMALS; HUMANS; MODELS, MOLECULAR; MOTOR ENDPLATE; MUTATION; MYASTHENIA GRAVIS; PROTEIN CONFORMATION; RECEPTORS, CHOLINERGIC; STRUCTURE-ACTIVITY RELATIONSHIP; SYNAPTIC TRANSMISSION;

EID: 84864060207     PISSN: 00319333     EISSN: 15221210     Source Type: Journal    
DOI: 10.1152/physrev.00015.2011     Document Type: Article

References (300)

1. Abraham SO, Scherf T, Eisenstein M, Chill JH, Anglister J. The mechanism for acetylcholine receptor inhibition by a-neurotoxinsand species-specific resistance to a-bun-garotoxin revealed by NMR. Neuron 35: 319-332, 2002.
2. Abramson SN, Li Y, Culver P, Taylor P. An analog of lophotoxin reacts covalently with Tyr190 in the alpha-subunit of the nicotinic acetylcholine receptor. J Biol Chem 264: 12666-12672, 1989.
3. Adams PR. An analysis of the dose-response curve at voltage-clamped frog-endplates. Pflügers Arch 360: 145-153, 1975.
4. Akabas MH, Kaufmann C, Archdeacon P, Karlin A. Identification of acetylcholine receptor channel-lining residues in the entire M2 segment of the alpha subunit. Neuron 13: 919-927, 1994.
5. Akabas MH, Stauffer DA, Xu M, Karlin A. Acetylcholine receptor channel structure probed in cysteine-substitution mutants. Science 258: 307-310, 1992.
6. Akk G. Aromatics at the murine nicotinic receptor agonist binding site: mutational analysis of the alphaY93 and alphaW149 residues. J Physiol 535: 729-740, 2001.
7. Akk G, Auerbach A. Inorganic, monovalent cations compete with agonists for the transmitter binding site of nicotinic acetylcholine receptors. BiophysJ 70: 2652-2658, 1996.
8. Akk G, Zhou M, Auerbach A. A mutational analysis of the acetylcholine receptor channel transmitter binding site. BiophysJ 76: 207-218, 1999.
9. Anderson CR, Stevens CF. Voltage clamp analysis of acetylcholine produced end-plate current fluctuations at frog neuromuscular junction. J Physiol 235: 655-691, 1973.
10. Auerbach A, Lingle CJ. Activation of the primary kinetic modes of large- and small-conductance cholinergic ion channels in Xenopus myocytes. J Physiol 393: 437-466, 1987.
11. Avramopoulou V, Mamalaki A, Tzartos SJ. Soluble, oligomeric, ligand-binding extracellular domain of the human alpha7 acetylcholine receptor expressed in yeast: replacement of the hydrophobic cysteine loop by the hydrophilic loop of the ACh-binding protein enhances protein solubility. J Biol Chem 279: 38287-38293, 2004.
12. Bakus GJ. Chemical defense mechanisms on the Great Barrier Reef, Australia. Science 211: 497-499, 1981.
13. Barchan D, Kachalsky S, Neumann D, Vogel Z, Ovadia M, Kochva E, Fuchs S. How the mongoose can fight the snake: the binding site of the mongoose acetylcholine receptor. Proc Natl Acad Sci USA USA 89: 7717-7721, 1992.
14. Barchan D, Ovadia M, Kochva E, Fuchs S. The binding site of the nicotinic acetylcholine receptor in animal species resistant to alpha-bungarotoxin. Biochemistry 34: 9172-9176, 1995.
15. Barlow RB, Howard JAK, Johnson O. Structures of nicotine monomethyl iodide and nicotine monohydrogen iodide. Acta Cryst C42: 853-856, 1986.
16. Barlow RB, Johnson O. Relations between structure and nicotine-like activity: X-ray crystal structure analysis of (-)-cytisine and (-)-lobeline hydrochloride and a comparison with (-)-nicotine and other nicotine-like compounds. Br J Pharmacol 98: 799-808, 1989.
17. Bartol TM Jr, Land BR, Salpeter EE, Salpeter MM. Monte Carlo simulation of miniature endplate current generation in the vertebrate neuromuscular junction. BiophysJ 59: 1290-1307, 1991.
18. Basus VJ, Song G, Hawrot E. NMR solution structure of an alpha-bungarotoxin/nico-tinic receptor peptide complex. Biochemistry 32: 12290-12298.
19. Beckstein O, Sansom MS. The influence of geometry, surface character, and flexibility on the permeation of ions and water through biological pores. Phys Biol 1: 42-52, 2004.
20. Betzel C, Lange G, Pal GP, Wilson KS, Maelicke A, Saenger W. The refined crystal structure of alpha-cobratoxin from Naja naja siamensis at 2.4-A resolution. J Biol Chem 266:21530-21536, 1991.
21. Biesecker G. Molecular properties of the cholinergic receptor purified from Electro-phorus electricus. Biochemistry 12:4403-4409, 1973.
22. Blanton MP, Cohen JB. Mapping the lipid-exposed regions in the Torpedo californica nicotinic acetylcholine receptor. Biochemistry 31: 3738-3750, 1992.
23. Blount P, Merlie JP. Molecular basis of the two nonequivalent ligand binding sites of the muscle nicotinic acetylcholine receptor. Neuron 3: 349-357, 1989.
24. Blount P, Merlie JP. Native folding of an acetylcholine receptor alpha subunit expressed in the absence of other receptor subunits.JBiol Chem 263: 1072-1080, 1988.
25. Bocquet N, Nury H, Baaden M, Le Poupon C, Changeux JP, Delarue M, Corringer PJ. X-ray structure of a pentameric ligand-gated ion channel in an apparently open conformation. Nature 457: 111-114, 2009.
26. Bocquet N, Prado de Carvalho L, Cartaud J, Neyton J, Le Poupon C, Taly A, Grutter T, Changeux JP, Corringer PJ. A prokaryotic proton-gated ion channel from the nicotinic acetylcholine receptor family. Nature 445: 116-119, 2007.
27. Bon F, Lebrun E, Gomel J, Van Rapenbusch R, Cartaud J, Popot JL, Changeux JP. Image analysis of the heavy form of the acetylcholine receptor from Torpedo marmorata.J Mol Biol 176: 205-237, 1984.
28. Bourne Y, Radic Z, Aráoz R, Talley TT, Benoit E, Servent D, Taylor P, Molgó J, Marchot P. Structural determinants in phycotoxins and AChBP conferring high affinity binding and nicotinic AChR antagonism. Proc Natl Acad Sci USA USA 107: 6076-6081, 2010.
29. Bourne Y, Talley TT, Hansen SB, Taylor P, Marchot P. Crystal structure of a Cbtx-AChBP complex reveals essential interactions between snake alpha-neurotoxins and nicotinic receptors. EMBOJ 24: 1512-1522, 2005.
30. Bouzat C, Bren N, Sine SM. Structural basis of the different gating kinetics of fetal and adult acetylcholine receptors. Neuron 13: 1395-1402, 1994.
31. Bouzat C, Gumilar F, Spitzmaul G, Wang HL, Rayes D, Hansen SB, Taylor P, Sine SM. Coupling of agonist binding to channel gating in an ACh-binding protein linked to an ion channel. Nature 430, 896-900, 2004.
32. Brejc K, van Dijk WJ, Klaassen RV, Schuurmans M, van Der Oost J, Smit AB, Sixma TK. Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature 411: 269-276, 2001.
33. Bren N, Sine SM. Hydrophobic pairwise interactions stabilize a-conotoxin MI in the muscle acetylcholine receptor binding site. J Biol Chem 275: 12692-12700, 2000.
34. Bren N, Sine SM. Identification of residues in the adult nicotinic acetylcholine receptor that confer selectivity for curariform antagonists. J Biol Chem 272: 30793-30798, 1997.
35. Brett RS, Dilger JP, Adams PR, Lancaster B. A method for the rapid exchange of solutions bathing excised membrane patches. BiophysJ 50: 987-992, 1986.
36. Brisson A, Unwin PNT. Tubular crystals of acetylcholine receptor. J Cell Biol 99: 1202-1211, 1984.
37. Brooks B, Karplus M. Normal modes for specific motions of macromolecules: application to the hinge-bending mode of lysozyme. Proc Natl Acad Sci USA USA 82: 4995-4999, 1985.
38. Burzomato V, Beato M, Groot-Kormelink PJ, Colquhoun D, Sivilotti LG. Single-channel behavior of heteromeric alpha1beta glycine receptors: an attempt to detect a conformational change before the channel opens.J Neurosci 24: 10924-10940, 2004.
39. Cadugan DJ, Auerbach A. Conformational dynamics of the alphaM3 transmembrane helix during acetylcholine receptor channel gating. BiophysJ 93: 859-865, 2007.
40. Canepa FG, Pauling P, Sörum H. Structure of acetylcholine and other substrates of cholinergic systems. Nature 210: 907-909, 1966.
41. Carter CR, Cao L, Kawai H, Smith PA, Dryden WF, Raftery MA, Dunn SM. Chain length dependence of the interactions of bisquaternary ligands with the Torpedo nicotinic acetylcholine receptor. Biochem Pharmacol 73: 417-426, 2007.
42. Cashin AL, Torrice MM, McMenimen KA, Lester HA, Dougherty DA. Chemical-scale studies on the role of a conserved aspartate in preorganizing the agonist binding site of the nicotinic acetylcholine receptor. Biochemistry 46: 630-639, 2007.
43. Celie PH, Kasheverov IE, Mordvintsev DY, Hogg RC, van Nierop P, van Elk R, van Rossum-Fikkert SE, Zhmak MN, Bertrand D, Tsetlin V, Sixma TK, Smit AB. Crystal structure of nicotinic acetylcholine receptor homolog AChBP in complex with an alpha-conotoxin PnIA variant. Nat Struct Mol Biol 12: 582-588, 2005.
44. Celie PH, Klaassen RV, van Rossum-Fikkert SE, van Elk R, van Nierop P, Smit AB, Sixma TK. Crystal structure of acetylcholine-binding protein from Bulinus truncatus reveals the conserved structural scaffold and sites of variation in nicotinic acetylcholine receptors. J Biol Chem 280: 26457-26466, 2005.
45. Celie PH, van Rossum-Fikkert SE, van Dijk WJ, Brejc K, Smit AB, Sixma TK. Nicotine and carbamylcholine binding to nicotinic acetylcholine receptors as studied in AChBP crystal structures. Neuron 41: 907-914, 2004.
46. Chakrapani S, Bailey TD, Auerbach A. Gating dynamics of the acetylcholine receptor extracellular domain. J Gen Physiol 123: 341-356,2004.
47. Chakrapani S, Bailey TD, Auerbach A. The role of loop 5 in acetylcholine receptor channel gating. J Gen Physiol 122: 521-539, 2003.
48. Chang CC, Lee CY. Isolation of neurotoxins from the venom of Bungarus multicinctus and their modes of neuromuscular blocking action. Arch Int Pharmacodyn Ther 144: 241-57, 1963.
49. Charnet P, Labarca C, Leonard RJ, Vogelaar NJ, Czyzyk L, Gouin A, Davidson N, Lester HA. An open-channel blocker interacts with adjacent turns of alpha-helices in the nicotinic acetylcholine receptor. Neuron 4: 87-95, 1990.
50. Chen J, Zhang Y, Akk G, Sine SM, Auerbach A. Activation kinetics of recombinant mouse nicotinic acetylcholine receptors with mutations at a subunit residue tyrosine 190. BiophysJ 69: 849-859, 1995.
51. Cheng X, Lu B, Grant B, Law RJ, McCammon JA. Channel opening motion of alpha7 nicotinic acetylcholine receptor as suggested by normal mode analysis. J Mol Biol 355: 310-324, 2006.
52. Cheng X, Wang HL, Grant B, Sine SM, McCammon JA. Targeted molecular dynamics study of C-loop closure and channel gating in nicotinic receptors. PLos Comp Biol 2: 1173-1184, 2006.
53. Chennubhotla C, Rader AJ, Yang LW, Bahar I. Elastic network models for understanding biomolecular machinery: from enzymes to supramolecular assemblies. Phys Biol 2: S173-180, 2005.
54. Chiara DC, Cohen JB. Identification of amino acids contributing to high and low affinity d-tubocurarine sites in the Torpedo nicotinic acetylcholine receptor. J Biol Chem 272: 32940-32950, 1997.
55. 3H]nicotine photoincorporation in the gamma-subunit of the Torpedo nicotinic acetylcholine receptor. FEBS Lett 423: 223-226, 1998.
56. Chuang LC, Yu HM, Chen C, Huang TH, Wu SH, Wang KT. Determination of three-dimensional solution structure of waglerin I, a toxin from Trimeresurus wagleri, using 2D-NMR and molecular dynamics simulation. Biochim Biophys Acta 1292: 145-155, 1996.
57. Claudio T, Ballivet M, Patrick J, Heinemann S. Nucleotide and deduced amino acid sequences of Torpedo californica acetylcholine receptorgamma subunit. Proc Natl Acad Sci USA 80: 1111-1115, 1983.
58. Cockcroft VB, Osguthorpe DJ, Barnard EA, Lunt GG. Modeling of agonist binding to the ligand-gated ion channel superfamily of receptors. Proteins 8: 386-397, 1990.
59. Codding PW, James MNG. The crystal and molecular structure of a potent neuromuscular blocking agent: d-tubocurarine dichloride pentahydrate. Acta Cryst 29: 935-942, 1973.
60. 3H]acetylcholine mustard identifies residues in the cation-binding subsite.J Biol Chem 266: 23354-23364, 1991.
61. Colquhoun D. Binding, gating, affinity and efficacy: the interpretation of structure-activity relationships for agonists and of the effects of mutating receptors. Br J Pharmacol 125: 924-947, 1998.
62. Colquhoun D, Hawkes AG. On the stochastic properties of single ion channels. ProcR Soc Lond B Biol Sci 211: 205-235, 1981.
63. Colquhoun D, Sakmann B. Fast events in single-channel currents activated by acetylcholine and its analogues at the frog muscle end-plate. J Physiol 369: 501-557, 1985.
64. Colquhoun D, Sakmann B. Fluctuations in the microsecond time range of the current through single acetylcholine receptor ion channels. Nature 294: 464-466, 1981.
65. Culver P, Fenical W, Taylor P. Lophotoxin irreversibly inactivates the nicotinic acetylcholine receptor by preferential association atone of the two primary agonist sites. J Biol Chem 259: 3763-3770, 1984.
66. Cymes GD, Grosman C. Pore-opening mechanism of the nicotinic acetylcholine receptor evinced by proton transfer. Nat Struct Mol Biol 15: 389-396, 2008.
67. Cymes GD, Grosman C, Auerbach A. Structure of the transition state of gating in the acetylcholine receptor channel pore: a phi-value analysis. Biochemistry 41: 5548-5555, 2002.
68. Cymes GD, Ni Y, Grosman C. Probing ion-channel pores one proton at atime. Nature 438: 975-980, 2005.
69. Czajkowski C, Kaufmann C, Karlin A. Negatively charged amino acid residues in the nicotinic receptor delta subunit that contribute to the binding of acetylcholine. Proc Natl Acad Sci USA 90: 6285-6289, 1993.
70. Damle VN, Karlin A. Affinity labeling of one of two alpha-neurotoxin binding sites in acetylcholine receptor from Torpedo californica. Biochemistry 17: 2039-2045, 1978.
71. Dan Der Straaten TA, Kathawala G, Trellakis A, Eisenberg RS, Ravaioli U. BioMO-CHA-a Boltzmann transport Monte Carlo model for ion channel simulation. Mol Simul 31: 151-171, 2005.
72. Del Castillo J, Katz B. Interaction at end-plate receptors of different choline derivatives. Proc R Soc Lond B Biol Sci 146: 369-381, 1957.
73. Dellisanti CD, Yao Y, Stroud JC, Wang ZZ, Chen L. Crystal structure of the extracellular domain of nAChRalpha1 bound to alpha-bungarotoxin at 1.94 Å resolution. Nat Neurosci 10: 953-962, 2007.
74. Dionne VE, Steinbach JH, Stevens CF. An analysis of the dose-response relationship at voltage-clamped frog neuromuscular junctions. J Physiol 281: 421-444, 1978.
75. Donizelli M, Djite MA, Le Novère N. LGICdb: a manually curated sequence database after the genomes. Nucleic Acids Res 34: D267-269, 2006.
76. Dougherty DA. Cation-pi interactions in chemistry and biology: a new view of benzene, Phe, Tyr, and Trp. Science 271: 163-168, 1996.
77. + conduction and selectivity. Science 280: 69-77, 1998.
78. Dreyer F, Peper K, Sterz R. Determination of dose-response curves by quantitative ionophoresis at the frog neuromuscular junction. J Physiol 281: 395-419, 1978.
79. 2+ currents in a panel of "slow-channel syndrome" nicotinic receptor mutants. J Gen Physiol 133: 151-169, 2009.
80. Elliott J, Blanchard SG, Wu W, Miller J, Strader CD, Hartig P, Moore HP, Racs J, Raftery MA. Purification of Torpedo californica post-synaptic membranes and fractionation of their constituent proteins. BiochemJ 185:667-677, 1980.
81. Engel AG. The therapy of congenital myasthenic syndromes. Neurotherapeutics 4: 252-257, 2007.
82. Engel AG, Hohlfeild R. Disturbances of neuromuscular transmission: acquired autoimmune gyasthenia gravis. In: Myology (3rd ed.), edited by Engel AG, Francini-Arm-strong C. New York: McGraw-Hill, 2004, p. 1755-1790.
83. Engel AG, Ohno K, Sine SM. Congenital myasthenic syndromes. In: Myology (3rd ed.), edited by Engel AG, Francini-Armstrong C. New York: McGraw-Hill, 2004, p. 1801-1844.
84. Engel AG, Ohno K, Sine SM. Sleuthing molecular targets for neurological diseases: the neuromuscular junction as a paradigm. Nature Rev Neurosci 4: 339-352, 2003.
85. Fairclough RH, Twaddle GM, Gudipati E, Lin MY, Richman DP. Differential surface accessibility of alpha(187-199) in the Torpedo acetylcholine receptor alpha subunits. J Mol Biol 282: 317-330, 1998.
86. Fatt P, Katz B. An analysis of the end-plate potential recorded with an intracellular electrode. J Physiol 115: 320-370, 1951.
87. Fenical W, Okuda RK, Bandurraga MM, Culver P, Jacobs RS. Lophotoxin: a novel neuromuscular toxin from Pacific sea whips of the genus Lophogorgia. Science 212: 1512-1514, 1981.
88. Fersht AR, Leatherbarrow RJ, Wells TNC. Quantitative analysis of structure-activity relationships in engineered proteins by linear free-energy relationships. Nature 322: 284-286, 1986.
89. 125I-alpha-bungarotoxin binding at mouse neuromuscular junctions. J Cell Biol 69: 144-158, 1976.
90. Fletcher GH, Steinbach JH. Ability of nondepolarizing neuromuscular blocking drugs to act as partial agonists at fetal and adult mouse muscle nicotinic receptors. Mol Pharmacol 49: 938-947, 1996.
91. Frauenfelder H, Leeson DT. The energy landscape in non-biological and biological molecules. Nat Struct Biol 5: 757-759, 1998.
92. Gao F, Bren N, Little A, Wang HL, Hansen S, Talley T, Taylor P, Sine SM. Curariform antagonists bind in different orientations to acetylcholine binding protein. J Biol Chem 278: 23020-23026, 2003.
93. Gao F, Burghardt T, Bren N, Hansen SB, Henchman R, Taylor P, McCammon JA, Sine SM. Acetylcholine-mediated conformational changes in acetylcholine-binding protein revealed by simulation and intrinsic tryptophan fluorescence. J Biol Chem 280: 8443-8451, 2005.
94. Galzi JL, Revah F, Black D, Goeldner M, Hirth C, Changeux JP. Identification of a novel amino acid alpha-tyrosine 93 within the cholinergic ligands-binding sites of the acetyl-choline receptor by photoaffinity labeling. Additional evidence for a three-loop model of the cholinergic ligands-binding sites. J Biol Chem 265: 10430-1047, 1990.
95. Gao F, Mer G, Toneli M, Hansen SB, Taylor P, Sine SM. Solution NMR of acetylcholine binding protein reveals agonist-mediated conformational change of the C-loop. Mol Pharmacol 70: 1230-1235, 2006.
96. Ginsborg BL, McLachlan EM, Martin AR, Searl JW. The computation of simulated endplate potentials. Proc R Soc Lond B Biol Sci 213: 233-242, 1981.
97. 3H]chlorpromazine. Proc Natl Acad Sci USA 83: 2719-2723, 1986.
98. 1H-NMR spectroscopy and molecular dynamics simulation with the explicit solvent water. Biochim Biophys Acta 1343: 327-334, 1997.
99. Gray WR, Luque A, Olivera BM, Barrett J, Cruz LJ. Peptide toxins from Conus geogra-phus venom. J Biol Chem 256: 4734-4740, 1981.
100. Gray WR, Rivier JE, Galyean R, Cruz LJ, Olivera BM. Conotoxin MI disulfide bonding and conformational states. J Biol Chem 258: 12247-12251, 1983.
101. Green WN, Claudio T. Acetylcholine receptor assembly: subunit folding and oli-gomerization occur sequentially. Cell 74: 57-69, 1993.
102. Grosman C. Free-energy landscapes of ion-channel gating are malleable: changes in the number of bound ligands are accompanied by changes in the location of the transition state in acetylcholine-receptor channels. Biochemistry 42: 14977-14987, 2003.
103. Grosman C, Auerbach A. Kinetic, mechanistic, and structural aspects of unliganded gating of acetylcholine receptor channels: a single channel study of second transmembrane segment 12' mutants. J Gen Physiol 115: 621-635, 2000.
104. Grosman C, Zhou M, Auerbach A. Mapping the conformational wave of acetylcholine receptor channel gating. Nature 403: 773-776, 2000.
105. Grutter T, Changeux JP. Nicotinic receptors in wonderland. Trends Biochem Sci 26: 459-463, 2001.
106. 125I-alpha-bungarotoxin binding activity to the alpha subunit of Torpedo acetylcholine receptor isolated by gel electrophoresis in sodium dodecyl sulfate.J Biol Chem 256: 8294-8297, 1981.
107. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch 391: 85-100, 1981.
108. Hamilton SL, McLaughlin M, Karlin A. Formation of disulfide-linked oligomers of acetylcholine receptor in membrane from Torpedo electric tissue. Biochemistry 18: 155-163, 1979.
109. Hansen SB, Radic' Z, Talley TT, Molles BE, Deerinck T, Tsigelny I, Taylor P. Tryptophan fluorescence reveals conformational changes in the acetylcholine binding protein. J Biol Chem 277: 41299-41302, 2002.
110. Hansen SB, Sulzenbacher G, Huxford T, Marchot P, Taylor P, Bourne Y. Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations. EMBOJ 24: 3635-3646, 2005.
111. Hansen S, Wang HL, Taylor P, Sine SM. On the origin of ion conductance in pentam-eric Cys-loop receptors.J Biol Chem 283: 36066-36070, 2008.
112. Harel M, Kasher R, Nicolas A, Guss JM, Balass M, Fridkin M, Smit AB, Brejc K, Sixma TK, Katchalski-Katzir E, Sussman JL, Fuchs S. The binding site of acetylcholine receptor as visualized in the X-ray structure of a complex between alpha-bungarotoxin and a mimotope peptide. Neuron 32: 265-275,2001.
113. Hatton CJ, Shelley C, Brydson M, Beeson D, Colquhoun D. Properties of the human muscle nicotinic receptor, of the slow-channel myasthenic syndrome mutant epsilonL221F, inferred from maximum likelihood fits.J Physiol 547: 729-760, 2003.
114. Heidmann T, Bernhardt J, Neumann E, Changeux JP. Rapid kinetics of agonist binding and permeability response analyzed in parallel on acetylcholine receptor rich membranes from Torpedo marmorata. Biochemistry 22: 5452-5459, 1983.
115. Henchman RH, Wang HL, Sine SM, Taylor P, McCammon JA. Asymmetric structural motions of the homomeric a7 nicotinic receptor ligand binding domain revealed by molecular dynamics simulation. BiophysJ 85: 3007-3018, 2003.
116. Henchman RH, Wang HL, Sine SM, Taylor P, McCammon JA. Ligand-induced conformational changes in the a7 nicotinic receptor ligand binding domain. BiophysJ 88: 2564-2576, 2005.
117. Heuser JE, Salpeter SR. Organization of acetylcholine receptors in quick-frozen, deep-etched, rotary-replicated Torpedo postsynaptic membrane. J Cell Biol 82:150-173, 1979.
118. Hilf RJ, Dutzler R. Structure of a potentially open state of a proton-activated penta-meric ligand-gated ion channel. Nature 457: 115-118, 2009.
119. Hilf RJ, Dutzler R. X-ray structure of a prokaryotic pentameric ligand-gated ion channel. Nature 452: 375-379, 2008.
120. Hodgkin AL, Huxley AF. Currents carried by sodium and potassium ions through the membrane of the giant axon of Loligo.J Physiol 116: 449-472, 1952.
121. Hodgkin AL, Huxley AF, Katz B. Measurement of current-voltage relations in the membrane of the giant axon of Loligo.J Physiol 116: 424-448, 1952.
122. Horovitz A, Fersht AR. Strategy for analysing the co-operativity of intramolecular interactions in peptides and proteins. J Mol Biol 214: 613-617, 1990.
123. Horovitz A, Serrano L, Avron B, bycroft M, Fersht AR. Strength and co-operativity of contributions of surface salt bridges to protein stability. J Mol Biol 216: 1031-1044, 1990.
124. Hummer G, Rasaiah JC, Noworyta JP. Water conduction through the hydrophobic channel of a carbon nanotube. Nature 414: 188-190, 2001.
125. Imoto K, Busch C, Sakmann B, Mishina M, Konno T, Nakai J, Bujo H, Mori Y, Fukuda K, Numa S. Rings of negatively charged amino acids determine the acetylcholine receptor channel conductance. Nature 335: 645-648, 1988.
126. Imoto K, Methfessel C, Sakmann B, Mishina M, Mori Y, Konno T, Fukuda K, Kurasaki M, Bujo H, Fujita Y. Location of a delta-subunit region determining ion transport through the acetylcholine receptor channel. Nature 324: 670-674, 1986.
127. Jackson MB. Dependence of acetylcholine receptor channel kinetics on agonist concentration in cultured mouse muscle fibres. J Physiol 397: 555-583, 1988.
128. Jackson MB. Kinetics of unliganded acetylcholine receptor channel gating. BiophysJ 49: 663-672, 1986.
129. Jackson MB. Perfection of a synaptic receptor: kinetics and energetics of the acetylcholine receptor. Proc Natl Acad Sci USA 86: 2199-2203, 1989.
130. Jackson MB. Spontaneous openings of the acetylcholine receptor channel. Proc Natl Acad Sci USA 81: 3901-3904, 1984.
131. Jencks WP. A primer for the Bema Hapothle. An empirical approach to the characterization of changing transition state structures. Chem Rev 85: 511-527, 1985.
132. Jenkinson DH. The antagonism of tubocurarine and substances which depolarize the motor end-plate. J Physiol 152: 309-324, 1960.
133. Jha A, Cadugan DJ, Purohit P, Auerbach A. Acetylcholine receptor gating at extracellular transmembrane domain interface: the cys-loop and M2-M3 linker.J Gen Physiol 130: 547-558, 2007.
134. + channel. Nature 423: 33-41, 2003.
135. Karlin A. Emerging structure of the nicotinic acetylcholine receptors. Nat Rev Neurosci 3: 102-114, 2002.
136. Karlin A, Holtzman E, Yodh N, Lobel P, Wall J, Hainfeld J. The arrangement of the subunits of the acetylcholine receptor of Torpedo californica.J Biol Chem 258: 6678-6681, 1983.
137. Karlin A, Winnik M. Reduction and specific alkylation of the receptor for acetylcholine. Proc Natl Acad Sci USA 60: 668-674, 1968.
138. Karplus M, McCammon JA. Molecular dynamics simulations of biomolecules. Nat Struct Biol 9: 646-652, 2002.
139. Katz B, Miledi R. The measurement of synaptic delay and the time course of acetylcholine release at the neuromuscular junction. Proc RSoc Lond B Biol Sci 161:483-495, 1965.
140. Katz B, Miledi R. The statistical nature of the acetycholine potential and its molecular components.J Physiol 224: 665-699, 1972.
141. Katz B, Thesleff S. A study of the desensitization produced by acetylcholine at the motor end-plate. J Physiol 138:63-80, 1957.
142. Kelley SP, Dunlop JI, Kirkness EF, Lambert JJ, Peters JA. Acytoplasmic region determines single-channel conductance in 5-HT3 receptors. Nature 424: 321-324, 2003.
143. Kistler J, Stroud RM. Crystalline arrays of membrane-bound acetylcholine receptor. Proc Natl Acad Sci USA 78: 3678-36782, 1981.
144. Korn SJ, Horn R. Statistical discrimination of fractal and Markov models of single-channel gating. BiophysJ 54: 871-877, 1988.
145. Krienkamp H, Sine SM, Maeda R, Taylor P. Glycosylation sites selectively interfere with a-toxin binding to the nicotinic acetylcholine receptor. J Biol Chem 269: 8108-8114, 1994.
146. Kubalek E, Ralston S, Lindstrom J, Unwin N. Location of subunits within the acetylcholine receptor by electron image analysis of tubular crystals from Torpedo marmorata.J Cell Biol 105: 9-18, 1987.
147. Kuffler SW, Yoshikami D. The number of transmitter molecules in a quantum: an estimate from iontophoretic application of acetylcholine at the neuromuscular synapse. J Physiol 251: 465-482, 1975.
148. Kurosaki T, Fukuda K, Konno T, Mori Y, Tanaka K, Mishina M, Numa S. Functional properties of nicotinic acetylcholine receptor subunits expressed in various combinations. FEBS Lett 214: 253-258, 1987.
149. Land BR, Salpeter EE, Salpeter MM. Acetylcholine receptor site density affects the rising phase of miniature endplate currents. Proc Natl Acad Sci USA 77: 3736-3740, 1980.
150. Lape R, Colquhoun D, Sivilotti LG. On the nature of partial agonism in the nicotinic receptor superfamily. Nature 454: 722-727, 2008.
151. Lape R, Krashia P, Colquhoun D, Sivilotti LG. Agonist and blocking actions of choline and tetramethylammonium on human muscle acetylcholine receptors. J Physiol 587: 5045-5072, 2009.
152. Law RJ, Henchman RH, McCammon JA. A gating mechanism proposed from a simulation of a human alpha7 nicotinic acetylcholine receptor. Proc Natl Acad Sci USA 102: 6813-6818, 2005.
153. Lee WY, Free CR, Sine SM. Binding to gating transduction in nicotinic receptors: Cys-loop energetically couples to pre-M1 and M2-M3 regions. J Neurosci 29: 3189-3199, 2009.
154. Lee WY, Sine SM. Invariant aspartic acid in muscle nicotinic receptor contributes selectively to the kinetics of agonist binding. J. Gen Physiol 124: 555-567, 2004.
155. Lee WY, Sine SM. Principal pathway coupling agonist binding to channel gating in the nicotinic receptor. Nature 438: 243-247, 2005.
156. 2+ binding sites. Proc Natl Acad Sci USA 99: 3210-3215, 2002.
157. Leonard RJ, Labarca CG, Charnet P, Davidson N, Lester HA. Evidence that the M2 membrane-spanning region lines the ion channel pore of the nicotinic receptor. Science 242: 1578-1581, 1988.
158. Levitt M, Sander C, Stern PS. Protein normal-mode dynamics: trypsin inhibitor, crambin, ribonuclease and lysozyme.J Mol Biol 181:423-447, 1985.
159. Lin WW, Smith LA, Lee CY. A study on the cause of death due to waglerin-I, a toxin from Trimeresurus wagleri. Toxicon 33: 111-114, 1995.
160. Linder TM, Quastel DM. A voltage-clamp study of the permeability change induced by quanta of transmitter at the mouse end-plate. J Physiol 281: 535-558, 1978.
161. Lindstrom J, Anholt R, Einarson B, Engel A, Osame M, Montal M. Purification of acetylcholine receptors, reconstitution into lipid vesicles, and study of agonist-induced cation channel regulation.J Biol Chem 255: 8340-8350, 1980.
162. Lindstrom J, Einarson B, Merlie J. Immunization of rats with polypeptide chains from Torpedo acetylcholine receptor causes an autoimmune response to receptors in rat muscle. Proc Natl Acad Sci USA 75: 769-773, 1978.
163. Lindstrom J, Merlie J, Yogeeswaran G. Biochemical properties of acetylcholine receptor subunits from Torpedo californica. Biochemistry 18: 4465-4470, 1979.
164. Magleby KL, Stevens CF. A quantitative description of end-plate currents. J Physiol 223: 173-197, 1972.
165. Maconochie DJ, Steinbach JH. Block by acetylcholine of mouse muscle nicotinic receptors, stably expressed in fibroblasts. J Gen Physiol 106: 113-147, 1995.
166. Makriyannis A, Sullivan RF, Mautner HG. Conformational relationships between analogs of acetylcholine and those of local anesthetics in solution. Proc Natl Acad Sci USA 69: 3416-3419, 1972.
167. Martin M, Czajkowski C, Karlin A. The contributions of aspartyl residues in the acetylcholine receptor gamma and delta subunits to the binding of agonists and competitive antagonists. J Biol Chem 271: 13497-134503, 1996.
168. Mayer ML, Armstrong N. Structure and function of glutamate receptor ion channels. Annu Rev Physiol 66: 161-181,2004.
169. McManus OB, Weiss DS, Spivak CE, Blatz AL, Magleby KL. Fractal models are inadequate for the kinetics of four different ion channels. BiophysJ 54: 859-870, 1988.
170. Meunier JC, Sealock R, Olsen R, Changeux JP. Purification and properties of the cholinergic receptor protein from Electrophorus electricus electric tissue. Eur J Biochem 45: 371-394, 1974.
171. Miledi R, Molinoff P, Potter LT. Isolation of the cholinergic receptor protein of Torpedo electric tissue. Nature 229: 554-557, 1971.
172. Milone M, Wang HL, Ohno K, Fukudome T, Pruitt JN, Bren N, Sine SM, Engel AG. Slow-channel myasthenic syndrome caused by enhanced activation, desensitization, and agonist binding affinity attributable to mutation in the M2 domain of the acetylcholine receptor alpha subunit. J Neurosci 17:5651-5665, 1997.
173. Milone M, Wang HL, Ohno K, Prince R, Fukudome T, Shen XM, Brengman J, Griggs R, Sine SM, Engel AG. Mode switching kinetics by a naturally occurring mutation in the cytoplasmic loop of the human acetylcholine receptors subunit. Neuron 20: 575-588, 1998.
174. Mishina M, Tobimatsu T, Imoto K, Tanaka K, Fujita Y, Fukuda K, Kurasaki M, Taka-hashi H, Morimoto Y, Hirose T. Location of functional regions of acetylcholine receptor alpha-subunit by site-directed mutagenesis. Nature 313: 364-369, 1985.
175. Mitra A, Bailey TD, Auerbach AL. Structural dynamics of the M4 transmembrane segment during acetylcholine receptor gating. Structure 12: 1909-1918, 2004.
176. Mitra A, Cymes GD, Auerbach A. Dynamics of the acetylcholine receptor pore at the gating transition state. Proc Natl Acad Sci USA 102: 15069-15074, 2005.
177. Mitra AK, McCarthy MP, Stroud RM. Three-dimensional structure of the nicotinic acetylcholine receptor and location of the major associated 43-kD cytoskeletal protein, determined at 22 Å by low dose electron microscopy and x-ray diffraction to 12.5 Å. J Cell Biol 109:755-774, 1989.
178. Miyazawa A, Fujiyoshi Y, Stowell M, Unwin N. Nicotinic receptor at 4.6 Å resolution: transverse tunnels in the channel wall. J Mol Biol 288: 765-786, 1999.
179. Miyazawa A, Fujiyoshi Y, Unwin N. Structure and gating mechanism of the acetylcholine receptor pore. Nature 423: 949-955, 2003.
180. Molles BE, Rezai P, Kline EF, McArdle JJ, Sine SM, Taylor P. Identification of residues at the alpha and epsilon subunit interfaces mediating species selectivity of Waglerin-1 for nicotinic acetylcholine receptors. J Biol Chem 277: 5433-5440, 2002.
181. Molles BE, Tsigelny I, Nguyen PD, Gao SX, Sine SM, Taylor P. Residues in the epsilon subunit of the nicotinic acetylcholine receptor interact to confer selectivity of waglerin-1 for the alpha-epsilon subunit interface site. Biochemistry 41: 7895-7906, 2002.
182. Monod J, Wyman J, Changeux JP. On the nature of allosteric transitions: a plausible model.J Mol Biol 12: 88-118, 1965.
183. Morris CE, Wong BS, Jackson MB, Lecar H. Single-channel currents activated by curare in cultured embryonic rat muscle. J Neurosci 3: 2525-2531, 1983.
184. Mukhtasimova N, Free C, Sine SM. Initial coupling of binding to gating mediated by conserved residues in muscle nicotinic receptor. J Gen Physiol 126: 23-39, 2005.
185. Mukhtasimova N, Lee WY, Wang HL, Sine SM. Detection and trapping of intermediate states priming nicotinic receptor channel opening. Nature 459: 451-454, 2009.
186. Mukhtasimova N, Sine SM. An intersubunit trigger of channel gating in the muscle nicotinic receptor. J Neurosci 27: 4110-4119, 2007.
187. Nastuk WL. Membrane potential changes at a single muscle end-plate produced by transitory application of acetylcholine with an electrically controlled microjet. Federation Proc 12: 102, 1953.
188. Nastuk WL, Hodgkin AL. The electrical activity of single muscle fibers. J Cell Comp Physiol 35: 39, 1950.
189. Neher E, Sakmann B, Steinbach JH. The extracellular patch clamp: a method for resolving currents through individual open channels in biological membranes. Pflügers Arch 375: 219-228, 1978.
190. Neher E, Steinbach JH. Local anaesthetics transiently block currents through single acetylcholine-receptor channels. J Physiol 277: 153-176, 1978.
191. 3H]acetylcholine by Torpedo postsynaptic membranes: stoichiometry and ligand interactions. Biochemistry 18:5464-5475, 1979.
192. Nirthanan S, Ziebell MR, Chiara DC, Hong F, Cohen JB. Photolabeling the Torpedo nicotinic acetylcholine receptor with 4-azido-2,3,5,6-tetrafluorobenzoylcholine, a partial agonist. Biochemistry 44: 13447-13456, 2005.
193. Noda M, Takahashi H, Tanabe T, Toyosato M, Furutani Y, Hirose T, Asai M, Inayama S, Miyata T, Numa S. Primary structure of alpha-subunit precursor of Torpedo californica acetylcholine receptor deduced from cDNA sequence. Nature 299: 793-797, 1982.
194. Noda M, Takahashi H, Tanabe T, Toyosato M, Kikyotani S, Furutani Y, Hirose T, Takashima H, Inayama S, Miyata T, Numa S. Structural homology of Torpedo californica acetylcholine receptor subunits. Nature 302: 528-532, 1983.
195. Noda M, Takahashi H, Tanabe T, Toyosato M, Kikyotani S, Hirose T, Asai M, Takashima H, Inayama S, Miyata T, Numa S. Primary structures of beta- and delta-subunit precursors of Torpedo californica acetylcholine receptor deduced from cDNA sequences. Nature 301: 251-255, 1983.
196. Nowak MW, Gallivan JP, Silverman SK, Labarca CG, Dougherty DA, Lester HA. In vivo incorporation of unnatural amino acids into ion channels in Xenopus oocyte expression system. Methods Enzymol 293: 504-529, 1998.
197. Ogden DC, Colquhoun D. Ion channel block by acetylcholine, carbachol and suberyl-dicholine at the frog neuromuscular junction. Proc RSoc Lond B Biol Sci 225: 329-355, 1985.
198. Ohana B, Gershoni JM. Comparison of the toxin binding sites of the nicotinic acetylcholine receptor from Drosophila to human. Biochemistry 29: 6409-6415, 1990.
199. Ohno K, Hutchinson DO, Milone M, Brengman JM, Bouzat C, Sine SM, Engel AG. Congenital myasthenic syndrome caused by prolonged acetylcholine receptor channel openings due to a mutation in the M2 domain of the epsilon subunit. Proc Natl Acad Sci USA 92: 758-762, 1995.
200. Ohno K, Quiram P, Milone M, Wang HL, Harper M, Pruitt JN, Brengman JM, Pao L, Fischbeck K, Crawford T, Sine SM, Engel AG. Congenital myasthenic syndromes due to heteroallelic nonsense/missense mutations in the acetylcholine receptor e subunit gene: identification and functional characterization of six new mutations. Hum Mol Genet 6: 753-766, 1997.
201. Ohno K, Wang HL, Milone M, Bren N, Brengman JM, Nakano S, Quiram P, Pruitt JN, Sine SM, Engel AG. Congenital myasthenic syndrome caused by decreased agonist binding affinity due to a mutation in the acetylcholine receptor epsilon subunit. Neuron 17: 157-170, 1996.
202. O'Leary ME, White MM. Mutational analysis of ligand-induced activation of the Torpedo acetylcholine receptor. J Biol Chem 267: 8360-8365, 1992.
203. Osaka H, Malany S, Kanter JR, Sine SM, Taylor P. Subunit interface selectivity of the alpha-neurotoxins for the nicotinic acetylcholine receptor. J Biol Chem 274: 9581-9586, 1999.
204. Osaka H, Malany S, Molles BE, Sine SM, Taylor P. Pairwise electrostatic interactions between a-neurotoxins and y, 8 and e subunits of the nicotinic acetylcholine receptor. J Biol Chem 275: 5478-5484, 2000.
205. Oswald RE, Changeux JP. Crosslinking of alpha-bungarotoxin to the acetylcholine receptor from Torpedo marmorata by ultraviolet light irradiation. FEBS Lett 139: 225-229, 1982.
206. Pedersen SE, Cohen JB. d-Tubocurarine binding sites are located at alpha-gamma and alpha-delta subunit interfaces of the nicotinic acetylcholine receptor. Proc Natl Acad Sci USA 87: 2785-2789.
207. Prince RJ, Sine SM. Acetylcholine and epibatidine binding to muscle acetylcholine receptors distinguish between concerted and uncoupled models. J Biol Chem 274: 19623-19629, 1999.
208. Prince RJ, Sine SM. Molecular dissection of subunit interfaces in the acetylcholine receptor: identification of residues that determine agonist selectivity. J Biol Chem 271: 25770-25777, 1996.
209. Purohit P, Auerbach A. Acetylcholine receptor gating at extracellular transmembrane domain interface: the "pre-M1" linker. J Gen Physiol 130: 559-568, 2007.
210. Purohit P, Auerbach A. Acetylcholine receptorgating: movement in the alpha-subunit extracellular domain. J Gen Physiol 130: 569-79, 2007.
211. Qin F, Auerbach A, Sachs F. Estimating single-channel kinetic parameters from idealized patch-clamp data containing missed events. BiophysJ 70: 264-280, 1996.
212. Quast U, Schimerlik M, Lee T, Witzemann TL, Blanchard S, Raftery MA. Ligand-induced conformation changes in Torpedo californica membrane-bound acetylcholine receptor. Biochemistry 17: 2405-2014, 1978.
213. Quiram P, Jones J, Sine SM. Pairwise interactions between neuronal a7 receptors and a-conotoxin ImI.J Biol Chem 274: 19517-19525, 1999.
214. Quiram P, McIntosh M, Sine SM. Pairwise interactions between neuronal a7 receptors and a-conotoxin PnIB.J Biol Chem 275: 4889-4996, 2000.
215. Quiram P, Sine SM. Identification of residues in the neuronal a7 receptor that confer selectivity for conotoxin ImI. J Biol Chem 273: 11001-11006, 1998.
216. Quiram P, Sine SM. Structural elements in a-conotoxin ImI essential for binding to neuronal a7 receptors.J Biol Chem 273: 11007-11011, 1998.
217. Raftery MA, Hunkapiller MW, Strader CD, Hood LE. Acetylcholine receptor: complex of homologous subunits. Science 208: 1454-1456, 1980.
218. Rayes D, De Rosa MJ, Sine SM, Bouzat C. Number and locations of agonist binding sites required to activate homomeric Cys-loop receptors. J Neurosci 29: 6022-6032, 2009.
219. 3H]chlorpromazine labels three amino acids of the acetylcholine receptor gamma subunit: implications for the alpha-helical organization of regions MII and for the structure of the ion channel. Proc Natl Acad Sci USA 87: 4675-4679, 1990.
220. Reynolds JA, Karlin A. Molecular weight in detergent solution of acetylcholine receptor from Torpedo californica. Biochemistry 17: 2035-2038, 1978.
221. Rosenberry TL. Quantitative simulation of endplate currents at neuromuscular junctions based on the reaction of acetylcholine with acetylcholine receptor and acetylcholinesterase. BiophysJ 26: 263-289, 1979.
222. Sakmann B, Methfessel C, Mishina M, Takahashi T, Takai T, Kurasaki M, Fukuda K, Numa S. Role of acetylcholine receptor subunits in gating of the channel. Nature 318: 538-543, 1985.
223. Sakmann B, Patlak J, Neher E. Single acetylcholine-activated channels show burst-kinetics in presence of desensitizing concentrations of agonist. Nature 286: 71-73, 1980.
224. Salpeter MM. Vertebrate neuromuscular junctions: general morphology, molecular organization and functional consequences. In: The Vertebrate Neuromuscular Junction. New York: Liss, 1987, p. 1-54.
225. Samson AO, Levitt M. Inhibition mechanism of the acetylcholine receptor by alpha-neurotoxins as revealed by normal-mode dynamics. Biochemistry 47: 4065-4070, 2008.
226. Scarselli M, Spiga O, Ciutti A, Bernini A, Bracci L, Leilli B, Lozzi L, Calamandrei D, Di Maro D, Klein S, Niccolai N. NMR structure of alpha-bungarotoxin free and bound to a mimotope of the nicotinic acetylcholine receptor. Biochem 41: 1457-1463, 2002.
227. Schmidt JJ, Weinstein SA, Smith LA. Molecular properties and structure-function relationships of lethal peptides from venom of Wagler's pit viper, Trimeresurus wagleri. Toxicon 30: 1027-1036, 1992.
228. Schreiber G, Fersht AR. Energetics of protein-protein interactions: analysis of the barnase-barstar interface by single mutations and double mutant cycles. J Mol Biol 248: 478-486, 1995.
229. Scott KA, Mautner HG. Sulfur and selenium isologs related to acetylcholine and choline. IX. Further comparative studies of the pharmacological effects of acetylcholine and its thio and seleno analogs and their hydrolysis products. Biochem Pharmacol 16: 1903-1918, 1967.
230. Sellin LC, Mattila K, Annila A, Schmidt JJ, McArdle JJ, Hyvönen M, Rantala TT, Kivistö T. Conformational analysis of a toxic peptide from Trimeresurus wagleri which blocks the nicotinic acetylcholine receptor. BiophysJ 70: 3-13, 1996.
231. Shefter E, Mautner HG. Acetylcholine and its thiolester and selenolester analogs: conformation, electron distribution, and biological activity. Proc Natl Acad Sci USA 63: 1253-1260, 1969.
232. Shen XM, Fukuda T, Ohno K, Sine SM, Engel AG. Novel AChR 8 subunit mutation causes myasthenia by interfering with inter-subunit communication essential for channel gating. J Clin Invest 180: 1867-1876,2008.
233. Sheridan RP, Nilakantan R, Dixon JS, Venkataraghavan R. The ensemble approach to distance geometry: application to the nicotinic pharmacophore. J Med Chem 29: 899-906, 1986.
234. Shi J, Koeppe JR, Komives EA, Taylor P. Ligand-induced conformational changes in the acetylcholine-binding protein analyzed by hydrogen-deuterium exchange mass spectrometry. J Biol Chem 281: 12170-71217, 2006.
235. Sigworth FJ. An example of analysis. In: Single-Channel Recording (1st ed.), edited by Sakmann B, NeherE, New York: Plenum, 1983.
236. Sigworth FJ. Design of the EPC-9, a computer-controlled patch-clamp amplifier. 1. Hardware.J Neurosci Methods 56: ES/*ME2, 1995.
237. Sine SM. Identification of equivalent residues in the y, e, and Ssubunits of the nicotinic receptor that contribute to a-bungarotoxin binding. J Biol Chem 272: 23521-23527, 1997.
238. Sine SM. Molecular dissection of subunit interfaces in the acetylcholine receptor: identification of residues that determine curare selectivity. Proc Natl Acad Sci USA 90: 9436-9440, 1993.
239. Sine SM. The nicotinic receptor ligand binding domain.J Neurobiol 53: 431-46, 2002.
240. Sine SM, Claudio T. Gamma- and delta-subunits regulate the affinity and the cooper-ativity of ligand binding to the acetylcholine receptor. J Biol Chem 266: 19369-19377, 1991.
241. Sine SM, Claudio T, Sigworth FJ. Activation of Torpedo acetylcholine receptors expressed in mouse fibroblasts. Single channel current kinetics reveal distinct agonist binding affinities. J Gen Physiol 96: 395-437, 1990.
242. Sine SM, Engel AG. Recent advances in Cys-loop structure and function. Nature 440: 448-455, 2006.
243. Sine SM, Kreienkamp HJ, Bren N, Maeda R, Taylor P. Molecular dissection of subunit interfaces in the acetylcholine receptor: identification of determinants of a-Cono-toxin M1 selectivity. Neuron 15: 205-211, 1995.
244. Sine SM, Ohno K, Bouzat C, Auerbach A, Milone M, Pruitt AG, Engel JN. Mutation of the acetylcholine receptor a-subunit causes a slow-channel myasthenic syndrome by enhancing agonist binding affinity. Neuron 15:229-239, 1995.
245. Sine SM, Quiram P, Papanikolaou F, Kreienkamp HJ, Taylor P. Conserved tyrosines in the a subunit of the nicotinic acetylcholine receptor stabilize quaternary ammonium groups of agonists and curariform antagonists. J Biol Chem 269: 8808-8816, 1994.
246. Sine SM, Shen XM, Wang HL, Brengmann JM, Lee WY, Bren N, Engel AG. Naturally-occurring mutations at the acetylcholine receptor binding site independently alter ACh binding and channel gating.J Gen Physiol 120: 483-496, 2002.
247. Sine SM, Steinbach JH. Acetylcholine receptor activation by a site-selective ligand: nature of brief open and closed states in BC3H-1 cells. J Physiol 370: 357-379, 1986.
248. Sine SM, Steinbach JH. Activation of acetylcholine receptors on clonal mammalian BC3H-1 cells by low concentrations of agonist. J Physiol 373: 129-162, 1986.
249. Sine SM, Steinbach JH. Agonists block currents through acetylcholine receptor channels. BiophysJ 46: 277-284, 1984.
250. Sine SM, Taylor P. Relationships between reversible antagonist occupancy and the functional capacity of the acetylcholine receptor. J Biol Chem 256: 6692-6699, 1981.
251. Sine SM, Taylor P. The relationship between agonist occupation and the permeability response of the cholinergic receptor revealed by bound cobra alpha-toxin. J Biol Chem 255: 10144-10156, 1980.
252. Sine SM, Wang HL, Bren N. Lysine scanning mutagenesis delineates structural model of the nicotinic receptor ligand binding domain.J Biol Chem 277: 28210-29223,2002.
253. Smit AB, Syed NI, Schaap D, van Minnen J, Klumperman J, Kits KS, Lodder H, van der Schors RC, van Elk R, Sorgedrager B, Brejc K, Sixma TK, Geraerts WP. Aglia-derived acetylcholine-binding protein that modulates synaptic transmission. Nature 411: 261-268, 2001.
254. Sobell HM, Sakore TD, Tavale SS, Canepa FG, Pauling P, Petcher TJ. Stereochemistry of a curare alkaloid: O,O',N-trimethyl-d-tubocurarine. Proc Natl Acad Sci USA 69: 2212-225, 1972.
255. Suchyna TM, Markin VS, Sachs F. Biophysics and structure of the patch and the gigaseal. Biophys J 97: 738-747, 2009.
256. Svinning T, Sörum H. A re-investigation of the crystal structure of acetylcholine bromide. Acta Cryst B31: 1581-1586, 1975.
257. Takai T, Noda M, Mishina M, Shimizu S, Furutani Y, Kayano T, Ikeda T, Kubo T, Takahashi H, Takahashi T. Cloning, sequencing and expression of cDNA for a novel subunit of acetylcholine receptor from calf muscle. Nature 315: 761-764, 1985.
258. Takeda K, Trautmann A. A patch-clamp study of the partial agonist actions of tubo-curarine on rat myotubes. J Physiol 349: 353-374, 1984.
259. Takeuchi A, Takeuchi N. On the permeability of end-plate membrane during the action of transmitter. J Physiol 154: 52-67, 1960.
260. Talley TT, Harel M, Hibbs RE, Radic Z, Tomizawa M, Casida JE, Taylor P. Atomic interactions of neonicotinoid agonists with AChBP: molecular recognition of the distinctive electronegative pharmacophore. Proc Natl Acad Sci USA 105: 7606-7611, 2008.
261. Taly A, Delarue M, Grutter T, Nilges M, Le Novère N, Corringer PJ, Changeux JP. Normal mode analysis suggests a quaternary twist model for the nicotinic receptor gating mechanism. Biophys J 88: 3954-3965, 2005.
262. Tasneem A, Iyer LM, Jakobsson E, Aravind L. Identification of the prokaryotic ligand-gated ion channels and their implications for the mechanisms and origins of animal Cys-loop ion channels. Genome Biol 6: R4, 2005.
263. Tierney ML, Osborn KE, Milburn PJ, Stowell MH, Howitt SM. Phylogenetic conservation of disulfide-linked, dimeric acetylcholine receptor pentamers in southern ocean electric rays. J Exp Biol 207: 3581-3590, 2004.
264. Tomaselli GF, McLaughlin JT, Jurman ME, Hawrot E, Yellen G. Mutations affecting agonist sensitivity of the nicotinic acetylcholine receptor. Biophys J 60: 721-727, 1991.
265. Toyoshima C, Unwin N. Ion channel of acetylcholine receptor reconstructed from images of postsynaptic membranes. Nature 336: 247-250, 1988.
266. Tzartos SJ, Changeux JP. High affinity binding of alpha-bungarotoxin to the purified alpha-subunit and to its 27,000-dalton proteolytic peptide from Torpedo marmorata acetylcholine receptor. Requirement for sodium dodecyl sulfate. EMBO J 2: 381-387, 1983.
267. Tzartos SJ, Lindstrom JM. Monoclonal antibodies used to probe acetylcholine receptor structure: localization of the main immunogenic region and detection of similarities between subunits. Proc Natl Acad Sci USA 77: 755-759, 1980.
268. Ulens C, Hogg RC, Celie PH, Bertrand D, Tsetlin V, Smit AB, Sixma TK. Structural determinants of selective alpha-conotoxin binding to a nicotinic acetylcholine receptor homolog AChBP. Proc Natl Acad Sci USA 103: 3615-3620, 2006.
269. Unwin N. Acetylcholine receptor channel imaged in the open state. Nature 373: 37-43, 1995.
270. Unwin N. Nicotinic acetylcholine receptor at 9 A resolution. J Mol Biol 229: 1101-1124, 1993.
271. Unwin N. Refined structure of the nicotinic receptor at 4 Å resolution. J Mol Biol 346: 967-989, 2005.
272. Unwin N, Miyazawa A, Li J, Fujiyoshi Y. Activation of the nicotinic acetylcholine receptor involves a switch in conformation of the alpha subunits. J Mol Biol 319: 1165-1176, 2002.
273. Vaughan CK, Harryson P, Buckle AM, Fersht A. A structural double-mutant cycle: estimating the strength of a buried salt bridge in barnase. Acta Cryst D Biol Cryst 58: 591-600, 2002.
274. Venkataramanan L, Sigworth FJ. Applying hidden Markov models to the analysis of single ion channel activity. Biophys J 82: 1930-1942, 2002.
275. Wang HL, Auerbach A, Bren N, Ohno K, Engel AG, Sine SM. Mutation in the M1 domain of the acetylcholine receptor alpha subunit decreases the rate of agonist dissociation. J Gen Physiol 109: 757-766, 1997.
276. Wang HL, Cheng X, Taylor P, McCammon JA, Sine SM. Control of cation permeation through the nicotinic receptor. PLos Comp Biol 4: 1-9, 2008.
277. Wang D, Chiara DC, Xie Y, Cohen JB. Probing the structure of the nicotinic acetylcholine receptor with 4-benzoylbenzoylcholine, a novel photoaffinity competitive antagonist. J Biol Chem 275: 28666-28674, 2000.
278. Wang HL, Gao F, Bren N, Sine SM. Curariform antagonists bind in different orientations to the nicotinic receptor ligand binding domain.J Biol Chem 278: 32284-32291, 2003.
279. Wang HL, Ohno K, Milone M, Brengman J, Evoli A, Batocchi AP, Middleton L, Christ-odoulou K, Engel AG, Sine SM. Fundamental gating mechanism of nicotinic receptor channel gating revealed by mutation causing a congenital myasthenic syndrome. J Gen Physiol 116: 449-460, 2000.
280. Wang HL, Toghraee R, Papke D, Cheng XL, McCammon JA, Ravaioli U, Sine SM. Single channel current through nicotinic receptor produced by closure of binding site C-loop. BiophysJ 96: 3582-3590, 2009.
281. 3H]alpha-toxin to membrane fragments from Electrophorus and Torpedo electric organs. I. Binding of the tritiated alpha-neurotoxin in the absence of effector. Mol Pharmacol 10: 1-14, 1974.
282. Weber M, David-Pfeuty T, Changeux JP. Regulation of binding properties of the nicotinic receptor protein by cholinergic ligands in membrane fragments from Torpedo marmorata. Proc Natl Acad Sci USA 72: 3443-3447, 1975.
283. Weerakoon P, Culurciello E, Yang Y, Santos-Sacchi J, Kindlmann PJ, Sigworth FJ. Patch clamp amplifiers on a chip. J Neurosci Methods 192: 187-192,2010.
284. Weiland G, Georgia B, Lappi S, Chignell CF, Taylor P. Kinetics of agonist-mediated transitions in state of the cholinergic receptor. J Biol Chem 252: 7648-7656, 1977.
285. Weiland G, Georgia B, Wee VT, Chignell CF, Taylor P. Ligand interactions with cholinergic receptor-enriched membranes from Torpedo: influence of agonist exposure on receptor properties. Mol Pharmacol 12: 1091-1105, 1976.
286. Weinstein SA, Schmidt JJ, Bernheimer AW, Smith LA. Characterization and amino acid sequences of two lethal peptides isolated from venom of Wagler's pit viper, Trim-eresurus wagleri. Toxicon 29: 227-236, 1991.
287. Wells GB, Anand R, Wang F, Lindstrom J. Water-soluble nicotinic acetylcholine receptor formed by alpha7 subunit extracellular domains. J Biol Chem 273: 964-973, 1998.
288. Wenningmann I, Dilger JP. The kinetics of inhibition of nicotinic acetylcholine receptors by (+)-tubocurarine and pancuronium. Mol Pharmacol 60: 790-796, 2001.
289. Williamson PT, Verhoeven A, Miller KW, Meier BH, Watts A. The conformation of acetylcholine at its target site in the membrane-embedded nicotinic acetylcholine receptor. Proc Natl Acad Sci USA 104: 18031-18036,2007.
290. Wilson GG, Karlin A. The location of the gate in the acetylcholine receptor channel. Neuron 20: 1269-1281, 1998.
291. Wilson PT, Lentz TL, Hawrot E. Determination of the primary amino acid sequence specifying the alpha-bungarotoxin binding site on the alpha subunit of the acetylcholine receptor from Torpedo californica. Proc Natl Acad Sci USA 82: 8790-8794, 1985.
292. Wise DS, Schoenborn BP, Karlin A. Structure of acetylcholine receptor dimer determined by neutron scattering and electron microscopy. J Biol Chem 256: 4124-4126, 1981.
293. Xiu X, Hanek AP, Wang J, Lester HA, Dougherty DA. A unified view of the role of electrostatic interactions in modulating the gating of Cys loop receptors. J Biol Chem 280: 41655-41666, 2005.
294. Young EF, Ralston E, Blake J, Ramachandran J, Hall ZW, Stroud RM. Topological mapping of acetylcholine receptor: evidence for a model with five transmembrane segments and a cytoplasmic COOH-terminal peptide. Proc Natl Acad Sci USA 82: 626-630, 1985.
295. Zafaralla GC, Ramilo C, Gray WR, Karlstrom R, Olivera BM, Cruz LJ. Phylogenetic specificity of cholinergic ligands: alpha-conotoxin SI. Biochemistry 27: 7102-7105, 1988.
296. Zeng H, Moise L, Grant MA, Hawrot E. The solution structureofthe complex formed between alpha-bungarotoxin and an 18-mer cognate peptide derived from the alpha 1 subunit of the nicotinic acetylcholine receptor from Torpedo californica. J Biol Chem 276: 22930-22940, 2001.
297. Zhang Y, Chen J, Auerbach A. Activation of recombinant mouse acetylcholine receptors by acetylcholine, carbamylcholine and tetramethylammonium. J Physiol 486: 189-206, 1995.
298. Zhong W, Gallivan JP, Zhang Y, Li L, Lester HA, Dougherty DA. From ab initio quantum mechanics to molecular neurobiology: a cation-pi binding site in the nicotinic receptor. Proc Natl Acad Sci USA 95: 12088-12093, 1998.
299. Zingsheim HP, Barrantes FJ, Frank J, Hänicke W, Neugebauer DC. Direct structural localization of two toxin-recognition sites on an ACh receptor protein. Nature 299: 81-84, 1982.
300. Zouridakis M, Zisimopoulou P, Eliopoulos E, Poulas K, Tzartos SJ. Design and expression of human alpha7 nicotinic acetylcholine receptor extracellular domain mutants with enhanced solubility and ligand-binding properties. Biochim Biophys Acta 1794: 355-66, 2009.